HBI speaks to Ewan Davis, partner at Quadria Capital, a private equity firm headquartered in Singapore. With offices in New Delhi and Ho Chi Minh, it invests in health care companies across South and Southeast Asia.
Indian hospital group Max Healthcare is appealing a court decision to reject its claim concerning Care Hospital, another Indian hospital group which it tried to acquire, which it made after the latter accepted an alternative offer from US private equity firm Blackstone.
Ramsay Sime Darby, the South East Asian branch of multinational Australian hospital giant Ramsay, is up for sale again. The owners are reportedly seeking a valuation of around $1.5bn, which would make it the largest health care deal in the South East Asian region since 2019.
The hype around artificial intelligence may have reached a new high, but the tools certainly aren’t recent. At HBI 2023, L.E.K. Consulting’s digital health lead Klaus Boehncke and L.E.K. partner Guillaume Duparc shared their perspectives on concerns around privacy and the adoption of AI, as well as advice on how to leverage data effectively.
As ageing populations collide with a shrinking workforce, nursing homes face an uncertain future. Covid thrust this oft taken-for-granted sector into the spotlight and in the wake of recent scandals in France, three experts weighed in on opportunities and trends in nursing homes at HBI 2023.
Rising costs from inflation, wages, and energy are indiscriminately hitting the health care sector and despite government support packages being pledged, the road ahead looks arduous. So how do providers control costs, and what are the strategies to keep costs at bay?
Emerging markets present opportunities you wouldn't find in more established geographies. In a panel entitled ‘investing in emerging markets’ at HBI 2023 in London, panellists explored where the most potential for investment in emerging markets lies. The main takeaways were:
HBI talks to Biju Mohandas, partner and global co-leader for healthcare investments at global impact investor LeapFrog Investments, about investment strategy, increased localisation of supply chains, and the opportunities and the risks of artificial intelligence.
As public health experts, governments, and the WHO ask questions about the risks posed by AI, HBI speaks to two market experts. Should we be concerned or optimistic about its increasing use, specifically in health care?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
